Cardiac surgery and catheterization in patients with haemophilia

Haemophilia

Volumn 6, Issue 2, 2000, Pages 84-88

  Mackinlay, N ^a,b   Taper, J ^a   Renisson, F ^a   Rickard, K ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Cardiac catheterization; Cardiac surgery; Haemophilia

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9 CONCENTRATE; BLOOD CLOTTING INHIBITOR; HEPATITIS B SURFACE ANTIGEN; WARFARIN;

ADULT; AGED; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CORONARY ARTERY BYPASS SURGERY; DRUG INFUSION; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART SURGERY; HEART VALVE REPLACEMENT; HEMOPHILIA; HEMOSTASIS; HEPATITIS B; HEPATITIS C; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; PERICARDIAL EFFUSION; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADOLESCENT; ADULT; AGED; AORTIC VALVE; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; FACTOR IX; FACTOR VIII; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HEMOPHILIA A; HEMOPHILIA B; HEMORRHAGE; HEMOSTASIS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HUMANS; ISOANTIBODIES; MIDDLE AGED; MYOCARDIAL ISCHEMIA; THORACIC SURGICAL PROCEDURES; WARFARIN;

EID: 0034020665     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2000.00384.x     Document Type: Article

References (25)

1. Jones PK, Ratnoff OD. The changing prognosis of classic haemophilia (factor VIII 'deficiency'). Ann Intern Med 1991; 114: 641.
2. Lovric AV, Margolis J, Rhoades P. Preparation of blood components: a method suitable for developing countries. Lancet 724-5, 1980.
3. Martinowitz U, Schulman S. Coagulation factor concentrates by continuous infusion. Transfus Med Rev 1997; 11: 56-63.
4. Schulman S, Martinowitz U. Continuous infusion instead of bolus injections of factor concentrate? Haemophilia 1996; 2: 189-91.
5. Rickard KA. Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery. Haemophilia 1995; (Suppl. 1) 8-13.
6. World Health Organisation/Health Document Program/World Health Modern treatment of Haemophilia. Report of the Joint WHO/WH Meeting on the Control of Haemophilia 1994; 94.6.
7. Meade TW, Mellows S, Brozovic M et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2 (8506): 533-7.
8. Rosendaal FR, Varekamp I, Smit C et al. Mortality and causes of death in Dutch haemophiliacs. 1973-86. Br J Haematol 1989; 71: 71-6.
9. Rizza CR, Spooner RJD. Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976-80: report on behalf of the directors of haemophilia centres in the United Kingdom. Br Med J 1983; 286: 929-33.
10. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol 1994; 88: 601-7.
11. Raish RJ, Witte DL, Goldsmith JC. Successful cardiac surgery following plasmapheresis in a patient with haemophilia B. Transfusion 1985; 25 (2): 128-30.
12. Legget PL, Doyle D, Smith WB, Culpepper W, IIICooper S, Oschner JL. Elective cardiac operation in a patient with severe haemophilia and acquired factor VIII antibodies. J Thorac Cardiovasc Surg 1984; 87 (4): 556-60.
13. Palanzo DA, Sadr FS. Coronary artery bypass grafting in a patient with haemophilia B. Perfusion 1995; 10: 266-70.
14. Vander Woude JC, Milam JD, Walker WE, Houchin DP, Weiland AP, Cooley DA. Cardiovascular surgery in patients with congenital plasma coagulopathies. Ann Thorac Surg 1988; 46 (3): 283-8.
15. Roskos RR, Gilchrist GS, Kazmier FJ, Feldt RH, Danielson GK. Management of haemophilia A and B during cardiac surgical correction of transposition of the great arteries. Mayo Clin Proc 1983; 58 (3): 182-6.
16. Martinowitz U, Schulman S, Gitel S, Horozowski H, Heim M, Varon D. Adjusted dose continuous infusion of factor FVIII in patients with haemophilia A. Br J Haematol 1992; 82: 729-34.
17. Hay CR, Doughtly HR, Savidge GF. Continuous infusion of factor FVIII for surgery and major bleeding. Blood Coagul Fibrinolysis 1996; 7 (Suppl. 1): S15-9.
18. Hathaway WE, Christian MJ, Clarke SL, Haslba V. Comparison of continuous and intermittent FVIII concentrate therapy in haemophilia A. Am J Haematol 1984; 17: 85-8.
19. Bona RD, Weinstein RA, Weisman SJ, Bartolomeo A, Rickles FR. The use of continuous infusion of factor concentrates in haemophilia. Am J Hematol 1989; 32: 8-13.
20. Campbell PJ, Rickard KA. Continuous and intermittent infusion of coagulation factor concentrates in patients undergoing surgery: a single centre Australian experience. Aust NZ J Med 1998; 28: 440-5.
21. Quick AJ. No aspirin for haemophiliacs. NEJM 1971; 284 (4): 218.
22. Quick AJ. Haemophilia and aspirin. JAMA 1970; 213 (10): 1689.
23. Mielke CH, Britten AFH. Use of aspirin or acetaminophen in haemophilia. NEJM 1970; 282 (22): 1270.
24. Kaneshiro MM, Mielke CH, Kasper CK, Rapaport SI. Bleeding time after aspirin in disorders of intrinsic clotting. NEJM 1969; 281 (19): 1039-42.
25. Kasper CK, Rapaport SI. Bleeding times and platelet aggregation after analgesics in haemophilia. Ann Int Med 1972; 77: 189-93.